T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
14/09/2020 - 3 minutes
TCR
How European Startups Have Advanced Cancer T-Cell Therapy in 2020
With the help of a huge €66M Series A round last week, the German startup…
11/08/2020 - 8 minutes
Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies
The German biotech Immatics will partner with GSK and could receive more than €1B from…
20/02/2020 - 3 minutes
UK Startup Snaps up Potential Universal Cancer Immunotherapy
The cancer vaccine developer Ervaxx has licensed a preclinical-stage ‘universal’ cancer immunotherapy based on the…
27/01/2020 - 2 minutes
T-Cell Discovery Could Herald Universal Cancer Immunotherapy
An international research team has found a new type of T-cell that could lead to…
21/01/2020 - 3 minutes
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
15/01/2020 - 2 minutes
How To Break Into The Crowded Immuno-Oncology Space
The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in…
11/09/2018 - 6 minutes
People with Innate Resistance to HIV Could Provide a Functional HIV Cure
In the process of studying HIV-infected patients who naturally don’t need therapy to…
08/06/2018 - 4 minutes
German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn
Medigene and bluebird bio are increasing the number of cancer targets against which to develop TCR…
14/05/2018 - 2 minutes
German Biotech Raises Record $270M Series A for Individualized Cancer Therapies
BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and…
04/01/2018 - 2 minutes
Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells
Scientists at Cardiff University have used CRISPR/Cas9 genome editing technology to produce highly specific killer T…
22/11/2017 - 3 minutes
Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for…
13/11/2017 - 3 minutes
